Hair loss affects approximately 6.5 million people in the UK, with androgenetic alopecia accounting for 95% of male hair loss and an increasing prevalence in women. The professional trichology market has expanded dramatically with new treatment modalities including exosome therapy, advanced mesotherapy cocktails, and medical-grade devices. This guide provides UK practitioners with a comprehensive overview of current treatment options.
Types of Hair Loss
Androgenetic Alopecia (AGA)
The most common form, affecting 50% of men by age 50 and up to 40% of women by age 70. Caused by dihydrotestosterone (DHT) miniaturising hair follicles in genetically susceptible areas. Progressive without treatment.
Telogen Effluvium
Diffuse shedding triggered by stress, illness, medication, or nutritional deficiency. Usually self-resolving once the trigger is identified and addressed, but can become chronic.
Alopecia Areata
Autoimmune-mediated patchy hair loss. May progress to alopecia totalis or universalis. Requires dermatological management.
Traction Alopecia
Caused by chronic tension on hair follicles from tight hairstyles. Reversible if identified early, but prolonged traction causes permanent follicular damage.
Professional Treatment Modalities
1. Exosome Therapy for Hair
EXO OX Hair represents the latest advancement in regenerative trichology. Plant-based exosomes deliver targeted growth factors and signalling molecules to hair follicles, stimulating:
- Wnt/β-catenin pathway activation (the primary growth signalling cascade for hair follicles)
- Dermal papilla cell proliferation
- Angiogenesis around follicular units
- Anti-inflammatory microenvironment
Clinical protocol: 4-6 sessions at 2-4 week intervals, applied via mesotherapy or microneedling. Maintenance sessions every 3-6 months. Combined with EXO OX Hair Serum for home use between sessions.
2. Mesotherapy for Hair
Mesoceutical cocktails designed for scalp injection deliver nutrients directly to the dermal papilla. Effective ingredients include:
- PDRN — Stimulates tissue repair and follicular regeneration
- Biotin — Essential B-vitamin for keratin production
- Dexpanthenol — Improves scalp hydration and follicular health
- Zinc and copper peptides — GHK-Cu has specific evidence for hair follicle support
3. Medical Devices
- LED therapy — Red light (650-670nm) and near-infrared (830nm) stimulate mitochondrial function in follicular cells. Professional LED systems deliver clinically validated wavelengths
- Microneedling — Medical pen at 0.5-1.5mm depth creates controlled micro-injuries that activate wound-healing growth factors. Significantly enhances absorption of topical growth factors and exosomes
- LLLT (Low-Level Laser Therapy) — FDA-cleared for AGA treatment. Most effective as maintenance and adjunct therapy
4. Drug Delivery Serums
The Hairox Deep Serum uses advanced drug delivery technology to enhance penetration of active ingredients through the scalp barrier, reaching the dermal papilla at concentrations not achievable with standard topical products.
5. Oral Supplements
Nutritional support is foundational for hair health:
- Hairox Plus — Targeted oral supplement with biotin, zinc, selenium, and botanical extracts
- Address underlying deficiencies: ferritin, vitamin D, zinc, biotin, iron
- Blood panel recommended before starting treatment to identify correctable causes
Comprehensive Treatment Protocol
Initial Assessment
- Detailed history: onset, pattern, family history, medications, diet, stress
- Trichoscopy examination: miniaturisation, follicular density, perifollicular signs
- Blood tests: FBC, ferritin, thyroid function, vitamin D, zinc, hormonal panel
- Photography: standardised before photos for progress tracking
Phase 1: Foundation (Months 1-3)
- Address nutritional deficiencies — Hairox Plus supplementation
- Scalp-optimising shampoo — Hairox Shampoo
- Daily topical treatment — Hairox Serum
- Bi-weekly in-clinic mesotherapy sessions
Phase 2: Intensive Treatment (Months 3-6)
- Continue home care regimen
- Monthly EXO OX Hair exosome treatments via microneedling
- LED therapy sessions (2x weekly if in-clinic, or home device daily)
- Consider Hairox 360 Kit for comprehensive oral + topical approach
Phase 3: Maintenance (Month 6+)
- Quarterly exosome maintenance sessions
- Continued home care (shampoo, serum, supplements)
- Tri-monthly trichoscopy for objective progress tracking
- Adjust protocol based on response
Comparing Hair Loss Treatments
| Treatment | Mechanism | Time to Results | Evidence Level |
|---|---|---|---|
| Exosome therapy | Growth factor signalling | 3-6 months | Growing clinical evidence |
| Mesotherapy | Direct nutrient delivery | 3-6 months | Moderate clinical evidence |
| Minoxidil | Vasodilation, follicle stimulation | 4-6 months | Strong (FDA approved) |
| Finasteride | DHT inhibition | 6-12 months | Strong (prescription only) |
| PRP | Growth factor release | 3-6 months | Moderate |
| LED/LLLT | Photobiomodulation | 3-6 months | Moderate (FDA cleared) |
| Microneedling | Wound healing cascade | 3-6 months | Growing clinical evidence |
Training and Education
Skymedic Academy offers a CPD-accredited Hair Restoration and Scalp Health Workshop covering:
- Trichoscopy and diagnostic assessment
- Mesotherapy injection technique for the scalp
- Exosome therapy protocols
- Device-based treatments (LED, microneedling)
- Patient management and progress tracking
Frequently Asked Questions
How do exosomes compare to PRP for hair loss?
Exosomes offer several advantages over PRP: consistent potency (not dependent on patient blood quality), no blood draw required, higher concentration of growth factors, and more targeted signalling. PRP results vary significantly between patients.
When should I refer to a dermatologist?
Refer when you suspect: alopecia areata, scarring alopecia, sudden diffuse shedding without clear trigger, suspected hormonal disorder, or when prescription treatment (finasteride/dutasteride) is indicated.
Can women use the same treatments as men?
Most treatments are suitable for both sexes. Key exceptions: finasteride is generally not recommended for pre-menopausal women due to teratogenic risk. Exosome therapy, mesotherapy, LED, and topical treatments are equally effective regardless of sex.